BioPharma Credit PLC (BPCR.L)
USD 0.89
(0.91%)
USD 0.89
(0.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 110.48 Million | 184.24 Million | 87.96 Million | 91.35 Million | 124.11 Million | 78.72 Million |
| Cost of Revenue | 25.24 Million | 33.89 Million | 15.89 Million | 18.65 Million | 27.59 Million | 18.55 Million |
| Gross Profit | 85.24 Million | 150.35 Million | 72.07 Million | 72.69 Million | 96.52 Million | 60.16 Million |
| Operating Expenses | 2.03 Million | 1.93 Million | 3.01 Million | 2.21 Million | 1.79 Million | 8.57 Million |
| Selling, General and Administrative Expenses | 2.03 Million | 1.89 Million | 3.05 Million | 2.11 Million | 1.79 Million | 4.68 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1000.00 | 36 Thousand | -47 Thousand | 102 Thousand | - | 3.89 Million |
| Cost and Expenses | 2.03 Million | 1.93 Million | 3.01 Million | 2.21 Million | 1.79 Million | 8.57 Million |
| Operating Income | 108.45 Million | 182.31 Million | 84.95 Million | 89.13 Million | 122.32 Million | 70.14 Million |
| Interest Expense | - | - | - | - | - | 3000.00 |
| Income Tax Expense | - | 182.31 Million | 84.95 Million | 89.13 Million | 122.32 Million | -161.14 Thousand |
| Earnings before Tax | 108.45 Million | 182.31 Million | 84.95 Million | 89.13 Million | 122.32 Million | 70.14 Million |
| Net Income | 108.45 Million | 182.31 Million | 84.95 Million | 89.13 Million | 122.32 Million | 70.14 Million |
| Earnings Per Share Basic | 0.08 | 0.13 | 0.06 | 0.06 | 0.09 | 0.05 |
| Earnings Per Share Diluted | 0.08 | 0.13 | 0.06 | 0.06 | 0.09 | 0.05 |
| Weighted Average Shares Outstanding | 1.3 Billion | 1.37 Billion | 1.37 Billion | 1.37 Billion | 1.37 Billion | 1.37 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.3 Billion | 1.37 Billion | 1.37 Billion | 1.37 Billion | 1.37 Billion | 1.37 Billion |
| Gross Margin | 0.77 | 0.82 | 0.82 | 0.80 | 0.78 | 0.76 |
| EBIT Margin | - | 0.99 | 0.97 | 0.98 | 0.99 | 0.89 |
| Profit Margin | 0.98 | 0.99 | 0.97 | 0.98 | 0.99 | 0.89 |
| EBITDA | - | - | - | - | - | - |
| Earnings Before Tax Margin | 0.98 | 0.99 | 0.97 | 0.98 | 0.99 | 0.89 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 39.57 Million | 39.57 Million | 28.61 Million | 110.48 Million | 28.61 Million | 39.25 Million |
| Cost of Revenue | 6.12 Million | - | 18.62 Million | 25.24 Million | - | - |
| Gross Profit | 33.45 Million | 39.57 Million | 9.98 Million | 85.24 Million | 28.61 Million | 39.25 Million |
| Operating Expenses | 3.6 Million | 3.6 Million | 9.84 Million | 2.03 Million | 9.84 Million | 3.79 Million |
| Selling, General and Administrative Expenses | 3.6 Million | 3.6 Million | 9.84 Million | - | 9.84 Million | 3.79 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.6 Million | 3.6 Million | 9.84 Million | 2.03 Million | 9.84 Million | 3.79 Million |
| Operating Income | 35.96 Million | 35.96 Million | 18.76 Million | 108.45 Million | 18.76 Million | 35.46 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 71.79 Million | - | -3500.00 | 108.45 Million | -3500.00 | - |
| Earnings before Tax | 35.91 Million | 35.91 Million | 18.76 Million | 108.45 Million | 18.76 Million | 35.46 Million |
| Net Income | 35.91 Million | 35.91 Million | 18.76 Million | 108.45 Million | 18.76 Million | 35.46 Million |
| Earnings Per Share Basic | 0.03 | 0.03 | 0.01 | - | 0.01 | 0.03 |
| Earnings Per Share Diluted | 0.03 | 0.03 | 0.01 | - | 0.01 | 0.03 |
| Weighted Average Shares Outstanding | 1.24 Billion | 1.24 Billion | 1.3 Billion | 1.37 Billion | 1.3 Billion | 1.31 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.24 Billion | 1.24 Billion | 1.3 Billion | 1.37 Billion | 1.3 Billion | 1.31 Billion |
| Gross Margin | 0.85 | 1.00 | 0.35 | 0.77 | 1.00 | 1.00 |
| EBIT Margin | 1.82 | 0.00 | -0.00 | - | -0.00 | - |
| Profit Margin | 0.91 | 0.91 | 0.66 | 0.98 | 0.66 | 0.90 |
| EBITDA | 71.83 Million | 44.5 Thousand | -3500.00 | - | -3500.00 | - |
| Earnings Before Tax Margin | 0.91 | 0.91 | 0.66 | 0.98 | 0.66 | 0.90 |
COTQF
RNC
600691
0I14
AZM
GLENMARK